The interaction of pyridoxal isonicotinoyl hydrazone (PIH) and salicylaldehyde isonicotinoyl hydrazone (SIH) with iron

被引:15
作者
Chen, Yu-Lin [1 ]
Kong, Xiaole [1 ]
Xie, Yuanyuan [2 ]
Hider, Robert C. [1 ]
机构
[1] Kings Coll London, Inst Pharmaceut Sci, 150 Stamford St, London SE1 9NH, England
[2] Zhejiang Univ Technol, Key Lab Green Pharmaceut Technol & Related Equipm, Minist Educ, Hangzhou, Zhejiang, Peoples R China
关键词
EFFECTIVE ANTIPROLIFERATIVE AGENTS; SYNTHETIC CHELATING-AGENTS; INTRACELLULAR IRON; THERAPEUTIC APPLICATION; IONIZATION CONSTANTS; MAMMALIAN-CELLS; ANALOGS; COMPLEXES; FLUORESCENCE; MOBILIZATION;
D O I
10.1016/j.jinorgbio.2017.12.007
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The interaction of pyridoxal isonicotinoyl hydrazone (PIH) and salicylaldehyde isonicotinoyl hydrazone (SIH), two important biologically active chelators, with iron has been investigated by spectrophotometric methods. High iron(III) affinity constants were determined for PIH, log beta(2) = 37.0 and SIH, log beta(2) = 37.6. The associated redox potentials of the iron complexes were determined using cyclic voltammetry at pH 7.4 as + 130 mV (vs normal hydrogen electrode, NHE) for PIH and + 136 mV(vs NHE) for SIH. These redox potentials are much higher than those corresponding to iron chelators in clinical use, namely deferiprone, - 620 my; desferasirox, - 600 mV and desferrioxamine, - 468 mV. Although the positive redox potentials of SIH and PIH are similar to that of EDTA, namely + 120 mV, the iron complexes of these two hydrazone chelators, unlike the iron complex of EDTA, do not redox cycle in the presence of vitamin C. These properties render PIH and SIH as excellent scavengers of iron, under biological conditions. Both SIH and PIH scavenge mononuclear iron(II) and iron(III) rapidly. These fast kinetic properties of the hydrazone-based chelators provide a ready explanation for the adoption of SIH in fluorescence-based methods for the quantification of cytosolic iron(Il).
引用
收藏
页码:194 / 203
页数:10
相关论文
共 56 条
[1]   IONIZATION CONSTANTS OF HETEROCYLIC SUBSTANCES .2. HYDROXY-DERIVATIVES OF NITROGENOUS SIX-MEMBERED RING-COMPOUNDS [J].
ALBERT, A ;
PHILLIPS, JN .
JOURNAL OF THE CHEMICAL SOCIETY, 1956, (JUN) :1294-1304
[2]   Hyperquad simulation and speciation (HySS): a utility program for the investigation of equilibria involving soluble and partially soluble species [J].
Alderighi, L ;
Gans, P ;
Ienco, A ;
Peters, D ;
Sabatini, A ;
Vacca, A .
COORDINATION CHEMISTRY REVIEWS, 1999, 184 :311-318
[3]  
[Anonymous], MARV SKETCH VERS 5 3
[4]   SYNTHESES OF IRON BIS(PYRIDOXAL ISONICOTINOYLHYDRAZONE)S AND THE INVIVO IRON-REMOVAL PROPERTIES OF SOME PYRIDOXAL DERIVATIVES [J].
AVRAMOVICIGRISARU, S ;
SAREL, S ;
LINK, G ;
HERSHKO, C .
JOURNAL OF MEDICINAL CHEMISTRY, 1983, 26 (02) :298-302
[5]   EVALUATION OF THE IRON CHELATION POTENTIAL OF HYDRAZONES OF PYRIDOXAL, SALICYLALDEHYDE AND 2-HYDROXY-1-NAPHTHYLALDEHYDE USING THE HEPATOCYTE IN CULTURE [J].
BAKER, E ;
RICHARDSON, D ;
GROSS, S ;
PONKA, P .
HEPATOLOGY, 1992, 15 (03) :492-501
[6]   IRON CHELATION BY PYRIDOXAL ISONICOTINOYL HYDRAZONE AND ANALOGS IN HEPATOCYTES IN CULTURE [J].
BAKER, E ;
VITOLO, ML ;
WEBB, J .
BIOCHEMICAL PHARMACOLOGY, 1985, 34 (17) :3011-3017
[7]   Hydrolysis of pyridoxal isonicotinoyl hydrazone and its analogs [J].
Buss, JL ;
Ponka, P .
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2003, 1619 (02) :177-186
[8]   Mobilization of intracellular iron by analogs of pyridoxal. isonicotinoyl hydrazone (PIH) is determined by the membrane permeability of the iron-chelator complexes [J].
Buss, JL ;
Arduini, E ;
Ponka, P .
BIOCHEMICAL PHARMACOLOGY, 2002, 64 (12) :1689-1701
[9]   A fluorescence assay for assessing chelation of intracellular iron in a membrane model system and in mammalian cells [J].
Cabantchik, ZI ;
Glickstein, H ;
Milgram, P ;
Breuer, W .
ANALYTICAL BIOCHEMISTRY, 1996, 233 (02) :221-227
[10]   BILIARY IRON EXCRETION IN RATS FOLLOWING PYRIDOXAL ISONICOTINOYL HYDRAZONE [J].
CIKRT, M ;
PONKA, P ;
NECAS, E ;
NEUWIRT, J .
BRITISH JOURNAL OF HAEMATOLOGY, 1980, 45 (02) :275-283